5. Sanofi spin-off: bidding war over the future of Pharma
In this episode of M&A Talks Europe, we dive into the high-stakes battle between private equity giants for Sanofi’s consumer medicine division, Opella, ultimately won by American CD&R for €15.5 billion. We’ll explore how this deal fits into broader trends in both the pharmaceutical and private equity sectors, Sanofi’s shift to biopharma, and the political uproar in France over healthcare sovereignty because of sale of Doliprane, most popular medicine in France. Tune in to learn more about pharma and carve-out deals!
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from M&A Talks Europe
4. German Industry meets Gulf Oil: Abu Dhabi takes over Covestro
3. How LVMH is helping Moncler’s CEO in a bid for control
2. Axel Springer-KKR: the €13.5 bln breakup of German media empire
1. Unicredit-Commerzbank: the biggest deal in EU banking
Get summaries like this every morning.
Free AI-powered recaps of M&A Talks Europe and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.